Cell and gene therapy (CGT) programs are rapidly advancing from research and development to clinical trials and commercial approval. Establishing a robust, repeatable, and sustainable process early on can help accelerate development and avoid manufacturing transfer-related delays.
Thermo Fisher Scientific has a long history of partnering with cell and gene therapy developers to help advance their therapies by providing innovative technologies, technical consultation, and services. We offer closed systems and single-use technologies (SUT) developed for cell and gene therapies and biologic development that offer the flexibility required to establish new processes while enabling standardization of processes at multiple scales. In addition to instrumentation and reagents, we offer expertise, services, and custom solutions to help you translate your cell therapy from discovery to clinical research and commercial manufacturing.
SUT provides robust solutions that reduce the risk of contamination. It is well understood that SUT shortens turnover time for equipment, which can help accelerate development. By establishing control platforms and replicable processes, cell and gene therapy developers can more efficiently scale up their solutions through clinical trials and commercial manufacturing.
Our BioProcess Containers (BPC) are flexible containment systems made from a catalog of proprietary polymer films. These films have been specifically designed to meet the needs of bioprocessing customers and are widely used in the bioprocessing industry. In addition, we offer a wide range of rigid, single-use consumables such as cell factory systems (for adherent cell culture), bottles, and fluid transfer assemblies.
As you scale your processes, we offer single-use equipment for adherent and suspension cell lines, including bioreactors and mixers from bench scale to production. These products meet specific cell and gene therapy needs, such as low shear cell processing.
In cell therapy, closed manufacturing systems are designed to minimize contamination risks and reduce ISO cleanroom requirements. In combination with digital connectivity, these systems enable repeatable, trackable, and GMP-compliant manufacturing processes.
For cell therapy manufacturing, we currently provide multiple closed systems with SUT consumables, including the Gibco CTS Rotea Counterflow Centrifugation System and the Thermo Scientific HyPerforma Rocker Bioreactor. The Rotea System is a closed and automated cell-processing system that provides process flexibility and enables cell separation, wash, concentration, and buffer exchange.
A compact, flexible closed cell processing system, designed to streamline and expedite your cell therapy development, that enables:
A closed, scalable electroporation system for GMP-compliant cell therapy manufacturing
Many of our CTS media and reagents designed for cell and gene therapy applications are available in a format designed to be used in your closed system workflow. Closed system-compatible media is provided in a BioProcess Container (BPC) designed with a variety of options suitable for aseptic integration into your workflow including sterile welding, MPC, Luer lock, and a septum port.
To control your process and manage your data, we offer the HyPerforma G3Lab Controller and the TruBio control system, based on the robust DeltaV platform, helping you to develop GMP-compliant processes as you eliminate costly and time-consuming tech transfers later in your process.
Whether you are establishing a new process or need to improve your existing one, contact us to discuss how we might be able to help.
Request Information about Cell and Gene Therapy
Learn about our solutions to help you achieve your cell therapy goals from research to commercialization
Services and Support
Contact our experienced technical and regulatory support team for CTS products
Cell & Gene Therapy cGMP Manufacturing Services
Contact our experienced team for cell and gene therapy cGMP manufacturing services